Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease

Abstract This study investigated the surgical outcomes of Coats disease and the role of external drainage (XD) of subretinal fluid (SRF). The study is a multicenter retrospective interventional case series of 26 consecutive eyes of 26 patients who underwent surgeries for advanced Coats disease with...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Fukutaro Mano, Itsuka Matsushita, Hiroyuki Kondo, Shoko Utamura, Chiori Kondo, Shunji Kusaka
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/272cd79165954c0c84981ff8784ad710
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:272cd79165954c0c84981ff8784ad710
record_format dspace
spelling oai:doaj.org-article:272cd79165954c0c84981ff8784ad7102021-12-02T19:16:54ZVitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease10.1038/s41598-021-98968-92045-2322https://doaj.org/article/272cd79165954c0c84981ff8784ad7102021-09-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-98968-9https://doaj.org/toc/2045-2322Abstract This study investigated the surgical outcomes of Coats disease and the role of external drainage (XD) of subretinal fluid (SRF). The study is a multicenter retrospective interventional case series of 26 consecutive eyes of 26 patients who underwent surgeries for advanced Coats disease with retinal detachment. Main outcomes measured were: 1) comparison of complete SRF resolution with or without XD, and 2) variables that were associated with functional postoperative best-corrected visual acuity (BCVA) defined as BCVA of 0.1 or better, 3) intraocular vascular endothelial growth factor (VEGF) levels. Complete SRF resolution was achieved in all 14 eyes in which XD had been performed and in 75% of 12 eyes in which XD had not been performed (P = .03). Multivariable logistic regression analysis revealed that initial BCVA was the only variable associated with functional postoperative BCVA (odds ratio 3.24, 95% CI 0.93–11.33; P = .04). Markedly elevated VEGF levels were noted in the SRF compared with those in the vitreous humor (49,760 ± 52,990 vs. 707 ± 611 pg/mL, P = .03). XD seems to provide better anatomical success than without XD in the treatment of advanced Coats disease as XD could effectively eliminate substantial amount of VEGF in the SRF.Fukutaro ManoItsuka MatsushitaHiroyuki KondoShoko UtamuraChiori KondoShunji KusakaNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Fukutaro Mano
Itsuka Matsushita
Hiroyuki Kondo
Shoko Utamura
Chiori Kondo
Shunji Kusaka
Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease
description Abstract This study investigated the surgical outcomes of Coats disease and the role of external drainage (XD) of subretinal fluid (SRF). The study is a multicenter retrospective interventional case series of 26 consecutive eyes of 26 patients who underwent surgeries for advanced Coats disease with retinal detachment. Main outcomes measured were: 1) comparison of complete SRF resolution with or without XD, and 2) variables that were associated with functional postoperative best-corrected visual acuity (BCVA) defined as BCVA of 0.1 or better, 3) intraocular vascular endothelial growth factor (VEGF) levels. Complete SRF resolution was achieved in all 14 eyes in which XD had been performed and in 75% of 12 eyes in which XD had not been performed (P = .03). Multivariable logistic regression analysis revealed that initial BCVA was the only variable associated with functional postoperative BCVA (odds ratio 3.24, 95% CI 0.93–11.33; P = .04). Markedly elevated VEGF levels were noted in the SRF compared with those in the vitreous humor (49,760 ± 52,990 vs. 707 ± 611 pg/mL, P = .03). XD seems to provide better anatomical success than without XD in the treatment of advanced Coats disease as XD could effectively eliminate substantial amount of VEGF in the SRF.
format article
author Fukutaro Mano
Itsuka Matsushita
Hiroyuki Kondo
Shoko Utamura
Chiori Kondo
Shunji Kusaka
author_facet Fukutaro Mano
Itsuka Matsushita
Hiroyuki Kondo
Shoko Utamura
Chiori Kondo
Shunji Kusaka
author_sort Fukutaro Mano
title Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease
title_short Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease
title_full Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease
title_fullStr Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease
title_full_unstemmed Vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease
title_sort vitrectomy and external drainage of subretinal fluid containing high concentration of vascular endothelial growth factor for advanced coats disease
publisher Nature Portfolio
publishDate 2021
url https://doaj.org/article/272cd79165954c0c84981ff8784ad710
work_keys_str_mv AT fukutaromano vitrectomyandexternaldrainageofsubretinalfluidcontaininghighconcentrationofvascularendothelialgrowthfactorforadvancedcoatsdisease
AT itsukamatsushita vitrectomyandexternaldrainageofsubretinalfluidcontaininghighconcentrationofvascularendothelialgrowthfactorforadvancedcoatsdisease
AT hiroyukikondo vitrectomyandexternaldrainageofsubretinalfluidcontaininghighconcentrationofvascularendothelialgrowthfactorforadvancedcoatsdisease
AT shokoutamura vitrectomyandexternaldrainageofsubretinalfluidcontaininghighconcentrationofvascularendothelialgrowthfactorforadvancedcoatsdisease
AT chiorikondo vitrectomyandexternaldrainageofsubretinalfluidcontaininghighconcentrationofvascularendothelialgrowthfactorforadvancedcoatsdisease
AT shunjikusaka vitrectomyandexternaldrainageofsubretinalfluidcontaininghighconcentrationofvascularendothelialgrowthfactorforadvancedcoatsdisease
_version_ 1718376902740148224